Invion (ASX:IVX) secures services agreement with Pavay Biotech
03 Feb 2020 - A subsidiary of Invion (ASX:IVX), EpiTech Dermal Science, has signed an R&D services agreement with a leading China-based pharmaceutical group in the skin repair and treatment market.